Trial Profile
A Pilot Study of the Effects of BYETTA (Exenatide) on Weight Loss in Morbidly Obese Non Diabetic Patients Following Adjustable Gastric Banding.
Status:
Recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Exenatide (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Acronyms AGREE; ASC-AGREE
- 09 Apr 2009 New trial record